Pharmaceutical Company Again Protects Product in ANDA Litigation

A pharmaceutical company prevailed in additional patent infringement abbreviated new drug application (ANDA) litigation related to one of its products. Alison Baldwin led the litigation team that represented the pharmaceutical company in the matter, succeeding both in district court and on appeal.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.